Factset Research Systems Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$337.65M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: FDS stock price vs PG: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PG's multiple
Needs PG P/E.
Implied fair value · at FDS's multiple
Needs FDS P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
FACTSET RESEARCH SYSTEMS INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
The Procter & Gamble Company · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MOODYS CORP /DE/
FDS vs MCO
MARKETAXESS HOLDINGS INC
FDS vs MKTX
GLOBAL PAYMENTS INC
FDS vs GPN
FISERV INC
FDS vs FI
JACK HENRY & ASSOCIATES INC
FDS vs JKHY
PayPal Holdings, Inc.
FDS vs PYPL
COLGATE PALMOLIVE CO
FDS vs CL
KIMBERLY CLARK CORP
FDS vs KMB
CHURCH & DWIGHT CO INC /DE/
FDS vs CHD
CLOROX CO /DE/
FDS vs CLX
Johnson & Johnson
FDS vs JNJ
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe FDS deserves a premium for stronger margins and growth relative to PG, then a constructive buy/overweight view is reasonable because FDS is cheaper on P/E and EV/EBITDA while still showing better operating performance; if you require a larger discount to FDS-specific valuation ranges, wait for a pullback closer to the historical band low.
FDS trades at a clear valuation discount to PG on earnings, sales, and EBITDA multiples, which is consistent with the modeled upside to $361.66. However, the stock already sits above the upper end of its DCF range and near the top of its historical band, so the discount is not as large when viewed against FDS-specific valuation anchors.
Supporting Metrics